Company / Total Assets
ImmunityBio, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$501.9M
FY2025
5-year range
$362.4M / $504.5M
FY2021-FY2025
Trend
+31.1%
vs FY2024
Sector context
#140 of 214
Health Care
What the data says
At $502M, ImmunityBio, Inc.'s total assets ranks #140 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $143M in FY2019 to $504M in FY2023.
Based on SEC 10-K filings.
$502M in FY2025 with a 5-year CAGR of +17.8%.
Remained stable around $502M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +11.5%
- 5-Year CAGR
- +17.8%
- 10-Year CAGR
- -
Sector benchmark
#140 of 214 in Health CareTop 65% of 214This company $501.9M Sector average $7.5B
▼
-93.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.8%, indicating consistent growth.
- In FY2025, total assets increased 31.1% year-over-year.
- Ranks #140 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $501.9M | +31.1% |
| FY2024 | $382.9M | -24.1% |
| FY2023 | $504.5M | +39.2% |
| FY2022 | $362.4M | -22.7% |
| FY2021 | $468.9M | +111.8% |
| FY2020 | $221.4M | +54.7% |
| FY2019 | $143.1M | -21.3% |
| FY2018 | $181.9M | -27.3% |
| FY2017 | $250.4M | -21.1% |
| FY2016 | $317.5M | -13.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026